Interferons induce proteolytic degradation of TRAILR4

Biochemical and Biophysical Research Communications

Volumn 337, Issue 1, 2005, Pages 184-190

  Wicovsky, Andreas ^a   Siegmund, Daniela ^a   Wajant, Harald ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; IFN ; IFN ; Proteasome; TRAIL; TRAILR4

Indexed keywords

ALPHA1 INTERFERON; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; GAMMA INTERFERON; INTERFERON; PROTEASOME; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

APOPTOSIS; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 25844469913     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.039     Document Type: Article

References (15)

1. A. Almasan, and A. Ashkenazi Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy Cytokine Growth. Factor Rev. 14 2003 337 348
2. M.J. Smyth, K. Takeda, Y. Hayakawa, J.J. Peschon, M.R. van den Brink, and H. Yagita Nature' s TRAIL-on a path to cancer immunotherapy Immunity 18 2003 1 6
3. T.S. Griffith, S.R. Wiley, M.Z. Kubin, L.M. Sedger, C.R. Maliszewski, and N.A. Fanger Monocyte-mediated tumoricidal activity via the tumor necrosis factor related cytokine, TRAIL J. Exp. Med. 189 1999 1343 1354
4. N. Kayagaki, N. Yamaguchi, M. Nakayama, H. Eto, K. Okumura, and H. Yagita Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs J. Exp. Med. 189 1999 1451 1460
5. D. Siegmund, A. Hausser, N. Peters, P. Scheurich, and H. Wajant Tumor necrosis factor (TNF) and phorbol ester induce TNF-related apoptosis-inducing ligand (TRAIL) under critical involvement of NF-kappaB essential modulator (NEMO)/IKKgamma J. Biol. Chem. 276 2001 43708 43712
6. I. Rivera-Walsh, M. Waterfield, G. Xiao, A. Fong, and S.C. Sun NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death J. Biol. Chem. 276 2001 40385 40388
7. T.M. Baetu, H. Kwon, S. Sharma, N. Grandvaux, and J. Hiscott Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression J. Immunol. 167 2001 3164 3173
8. M. Chawla-Sarkar, D.J. Lindner, Y.F. Liu, B.R. Williams, G.C. Sen, R.H. Silverman, and E.C. Borden Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis Apoptosis 8 2003 237 249
9. L.M. Sedger, D.M. Shows, R.A. Blanton, J.J. Peschon, R.G. Goodwin, D. Cosman, and S.R. Wiley IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression J. Immunol 163 1999 920 926
10. E.-C. Shin, J.M. Ahn, C.H. Kim, Y. Choi, Y.S. Ahn, H. Kim, S.J. Kim, and J.H. Park IFN-γ induces cell death in human heptoma cells through a Trail/death receptor mediated apoptotic pathway Int. J. Cancer. 93 2001 262 268
11. K. Fruh, and Y. Yang Antigen presentation by MHC class I and its regulation by interferon-gamma Curr. Opin. Immunol. 11 1999 76 81
12. D. Siegmund, A. Wicovsky, I. Schmitz, K. Schulze-Osthoff, S. Kreuz, M. Leverkus, O. Dittrich-Breiholz, M. Kracht, and H. Wajant Death receptor-induced signaling pathways are differentially regulated by interferon-γ upstream of caspase-8 processing Mol. Cell. Biol. 25 2005 6363 6379
13. G. Pan, J. Ni, Y.F. Wei, G. Yu, R. Gentz, and V.M. Dixit An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science 277 1997 815 818
14. J.P. Sheridan, S.A. Marsters, R.M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C.L. Gray, K. Baker, W.I. Wood, A.D. Goddard, P. Godowski, and A. Ashkenazi Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 1997 818 821
15. S.A. Marsters, J.P. Sheridan, R.M. Pitti, A. Huang, M. Skubatch, J. Baldwin, J. Yuan, A. Gurney, A. Goddard, and A. Ashkenazi A novel receptor for Aop2L/TRAIL contains a truncated death domain All. Curr. Biol. 7 1997 1003 1006